Alpha Cognition Inc. (OTC:ACOGF – Get Free Report)’s share price shot up 3% on Friday . The company traded as high as C$0.51 and last traded at C$0.51. 81,399 shares traded hands during trading, an increase of 142% from the average session volume of 33,657 shares. The stock had previously closed at C$0.50.
Alpha Cognition Price Performance
The company has a 50 day simple moving average of C$0.57 and a 200-day simple moving average of C$0.48. The stock has a market capitalization of C$55.54 million, a P/E ratio of -3.92 and a beta of 2.86.
Alpha Cognition Company Profile
Alpha Cognition Inc, a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases.
Read More
- Five stocks we like better than Alpha Cognition
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MarketBeat Week in Review – 4/22 – 4/26
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Start Investing in Real Estate
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
